tirzepatide and liver function Can a patient with mildly deranged Tests (LFTs) type 2 diabetes start the Moujaro (tirzepatide) injection? Ever-Rising Fatty Liver Disease Gets

Srenson's thinking was coloured by the fact that a previous drug, Redux, approved in 1996 by the FDA for weight loss and launched with great fanfare, had to be withdrawn a year later after it was found to cause major heart attacks and to be largely ineffective

Quickstart Highlights Lipo-C is a compounded lipotropic injection not a peptide built around the MIC trio of methionine, inositol and choline , almost always with added cyanocobalamin (vitamin B12) and sometimes L-carnitine [1]

GLP-1s are very effective Studies show that patients who use GLP-1s typically lose 10-15% of their current body weight

Managing weight and glycaemic control in patients with both Hashimoto's thyroiditis and type 2 diabetes presents unique challenges, as hypothyroidism itself contributes to weight gain, insulin resistance, and metabolic dysfunction

What may feel like an eternity might actually only be a few minutes